A study to assess the effects of efgartigimod on emasiprubart in healthy adult participants
ARGX-113-2405
Phase 1 other active
Quick answer
A study to assess the effects of efgartigimod on emasiprubart in healthy adult participants for not applicable is a Phase 1 program (other) at Argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Argenx
- Indication
- not applicable
- Phase
- Phase 1
- Modality
- other
- Status
- active